ZHU YeQing

Mr. Zhu YeQing

  • Chairman of the Board and CEO, New Horizon HealthCouncil Member, China Cancer FoundationHonorary Vice Chairman, Zhejiang Provincial Bridge Association

Co-founder of New Horizon Health (6606.HK), Mr. Zhu is the Chairman of the Board and CEO of New Horizon Health, transforming the organization into one of the most recognized bio-tech companies in China. In Feb. 2021, New Horizon Health became the first Chinese cancer screening company successfully listed on the main board of HK Exchange.

Mr. Zhu led New Horizon Health through the development, clinical trail, regulatory approval, and commercialization of Pupu tube ®, ColoClear ® and UU tube ®. ColoClear® is the first and only cancer screening test received NMPA approval as well as the first and only colorectal cancer screening test recommended by China national colorectal cancer prevention and diagnostic guidelines. UU Tube® is the first NMPA-approved consumer self-testing product for H.Pylori and Pupu Tube® is the first NMPA-approved consumer self-testing product for FIT (fecal immunochemical test), a screening test for colon cancer.

Before joining New Horizon Health, Mr. Zhu served as the Managing Director of GE Capital Asia and held multiple leadership positions in GE China and Samsung C&T.

Mr. Zhu holds a Bachelor of Science degree in biology and earned his MBA degree both from Beijing University.